Page last updated: 2024-10-21

1,2-dimethylhydrazine and Leukemia

1,2-dimethylhydrazine has been researched along with Leukemia in 1 studies

1,2-Dimethylhydrazine: A DNA alkylating agent that has been shown to be a potent carcinogen and is widely used to induce colon tumors in experimental animals.
1,2-dimethylhydrazine : A member of the class of hydrazines that is hydrazine in which one of the hydrogens attached to each nitrogen is replaced by a methyl group. A powerful DNA alkylating agent and carcinogen, it is used to induce colon cancer in laboratory rats and mice.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Il'nitskiĭ, AP1
Ryzhova, NI1
Chudina, AP1
Nevzorova, NI1
Nekrasova, EA1

Other Studies

1 other study available for 1,2-dimethylhydrazine and Leukemia

ArticleYear
[Sodium nitrite-induced potentiation of spontaneous and 1,2-dimethylhydrazine-induced carcinogenesis in male mice F1 (C57 B1xCBA)].
    Voprosy onkologii, 2004, Volume: 50, Issue:6

    Topics: 1,2-Dimethylhydrazine; Animals; Carcinogens; Cocarcinogenesis; Drug Synergism; Leukemia; Lung Neopla

2004